Document Preview Unavailable

Erythropoiesis‐stimulating agents and incident malignancy in chronic kidney and end‐stage renal disease: A population‐based study

Yu‐Shan Huang; Ming‐Feng Li; Mei‐Chen Lin; Shih‐Hsiang Ou; Jen‐Hung Wang; et al.  Clinical and Translational Science Vol. 15, Iss. 9,  (Sep 2022): 2195-2205.

You might have access to this document